3 ASX Growth Stocks With Up To 34% Insider Ownership
In This Article:
The Australian market has shown positive momentum, rising 1.1% over the last week and 11% over the past year, with the Materials sector leading at a 3.2% increase. In this favorable environment, growth companies with significant insider ownership can be particularly compelling as they often indicate strong internal confidence in future performance.
Top 10 Growth Companies With High Insider Ownership In Australia
| Name | Insider Ownership | Earnings Growth |
| Hartshead Resources (ASX:HHR) | 13.9% | 102.6% |
| Cettire (ASX:CTT) | 28.7% | 26.7% |
| Acrux (ASX:ACR) | 14.6% | 115.6% |
| Clinuvel Pharmaceuticals (ASX:CUV) | 13.6% | 28.1% |
| Liontown Resources (ASX:LTR) | 16.4% | 69.7% |
| Catalyst Metals (ASX:CYL) | 17.5% | 75.7% |
| Hillgrove Resources (ASX:HGO) | 10.4% | 49.4% |
| Adveritas (ASX:AV1) | 21.1% | 103.9% |
| Plenti Group (ASX:PLT) | 12.8% | 106.4% |
| Change Financial (ASX:CCA) | 26.6% | 77.9% |
We're going to check out a few of the best picks from our screener tool.
Chrysos
Simply Wall St Growth Rating: ★★★★★☆
Overview: Chrysos Corporation Limited (ASX:C79) develops and supplies mining technology, with a market cap of A$707.27 million.
Operations: Chrysos generates revenue from the development and supply of mining technology.
Insider Ownership: 17.5%
Chrysos Corporation Limited demonstrates significant growth potential with high insider ownership. The company reported A$44.18 million in sales for FY2024, up from A$25.61 million the previous year, though it posted a net loss of A$0.704 million compared to a net income of A$0.443 million previously. Revenue is forecast to grow at 30.5% annually, outpacing the broader Australian market's 5.3%. Despite some dilution and recent insider selling, Chrysos is expected to achieve profitability within three years.
-
Click to explore a detailed breakdown of our findings in Chrysos' earnings growth report.
-
Our valuation report here indicates Chrysos may be overvalued.
Nanosonics
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Nanosonics Limited is a global infection prevention company with a market cap of A$975.65 million.
Operations: Nanosonics generates revenue primarily from its Healthcare Equipment segment, which amounted to A$170.01 million.
Insider Ownership: 15.1%
Nanosonics' earnings are forecast to grow significantly at 22.29% per year, outpacing the Australian market's 12.8%. Despite a decline in profit margins from 12% to 7.6%, the company trades at a discount of 37% below its estimated fair value. Recent financial results show sales of A$170.01 million and net income of A$12.97 million, down from A$19.88 million last year, with basic earnings per share falling to A$0.0429 from A$0.066.